Latest Clinical & Research News
Specialty: OB/GYN
Department Chair Nawal Nour, MD, MPH, MBA, reflects on U.S. News & World Report 2024-25 ranking Brigham and Women’s Hospital #1 in the nation for Obstetrics and Gynecology. She celebrates how the Department’s commitment to collaboration and transparency helps provide high quality, equitable OB/GYN care to patients.
Read More...
An increasing percentage of patients seeking in vitro fertilization (IVF) are obese, and many experience disappointing outcomes. Brigham researchers recently examined the impact of increasing BMI on IVF, obstetric, and perinatal outcomes, and they report largely similar outcomes across BMIs of 30 to 60.
Read More...
Researchers have validated a next generation sequencing (NGS)-based noninvasive prenatal test that uses quantitative counting template technology to detect RhD, C, c, E, K (Kell), and Fya (Dufy) fetal antigengenotypes from maternal blood samples in the ethnically-diverse U.S. population.
Read More...
Hadine Joffe, MD, of Brigham and Women’s Hospital, and colleagues recently undertook a rigorous scientific review of whether the menopause is associated with anxiety, schizophrenic psychosis, suicidality and other mental health disorders, as has been claimed.
Read More...
Obstetrician Louise Wilkins-Haug, MD, PhD, and endocrinologist Ellen Seely, MD, are leaders at the Brigham’s Center for Connected Postpartum Care. The pair discusses the need for this center, its multidisciplinary approach to care, and its early successes in managing hypertensive patients postpartum.
Read More...
Brigham gynecologist and clinical oncologist Naoko Sasamoto, MD, PhD, MPH, is focused on developing novel therapeutics that target the underlying causes of endometriosis, a disease that affects up to 10% of women of reproductive age and causes pelvic pain that can severely impact a patient’s quality of life.
Read More...
Brigham researchers report long-term outcomes of COMPARE-UF, a study of women who underwent procedural treatment of uterine fibroids. They say symptom severity and quality of life were comparable with surgical and nonsurgical uterine-sparing procedures, but only hysterectomy patients showed sustained relief at year 3.
Read More...
Long dosing of gonadotrophin-releasing hormone (GnRH) agonist is often used for individuals experiencing poor response to ovarian stimulation for in vitro fertilization. Brigham researchers report very-low-dose and ultra-low-dose Lupron downregulation led to similar outcomes of other protocols for poor responders.
Read More...
Researchers at Brigham and Women’s Hospital used information from two large U.S. cohorts to derive and validate a risk score that predicts clinically meaningful midlife declines in physical health and function among women. Importantly, the score is based on variables that are easy to obtain in clinical practice.
Read More...
A study conducted by six Brigham specialists explored the impact of men’s mental health on fertility treatment and found no difference in IVF outcomes among men with or without anxiety, regardless of antidepressant use. First author Zachary Walker, MD, discusses the paper’s key findings and clinical implications.
Read More...